OneWater Marine Q3: Margin Gains and Debt Reduction Counter a Revenue Dip
ONEW sits 51% above its 52-week low of $8.12.
Summary
OneWater Marine's Q3 FY2026 revenue fell 4% to $530.7M, but gross margins expanded to 24.0% and Adjusted EBITDA rose 15% to $37.8M. Debt paydown and credit facility amendments strengthened the balance sheet.
Key Events · Earnings and Guidance · ONEW
-
Revenue Miss, Margin Beat
Q3 revenue of $530.7M fell 4% YoY, missing the $553.7M consensus, but gross margin expanded 70bps to 24.0% driven by new boat margin improvement to 17.9%.
-
Adjusted EBITDA Up 15%
Adjusted EBITDA rose to $37.8M from $32.8M a year ago, reflecting cost discipline and higher-margin sales mix.
-
Debt Reduction and Facility Amendments
Leverage ratio improved to 3.7x after repaying $50M in debt with Ocean Bio-Chem sale proceeds. The A&R Credit Facility maturity was extended to July 2027, and the Inventory Financing Facility was amended with a $497.1M capacity.
-
Restructuring and Impairment Charges
Nine-month restructuring and impairment charges totaled $14.3M, including a $5.8M trade name impairment from internal realignment and costs from location closures and headcount reductions.
Analysis · ONEW · Trade & Services
OneWater Marine's fiscal Q3 tells a story of two opposing trends. While revenue slipped 4% to $530.7M, missing consensus, gross margins widened 70 basis points to 24.0%, fueled by a jump in new boat margins to 17.9%. Adjusted EBITDA climbed 15% to $37.8M, and leverage fell to 3.7x after the company used proceeds from the Ocean Bio-Chem sale to pay down $50M in debt. The credit facility maturity was extended to July 2027, with a further amendment in progress. Restructuring charges of $14.3M over nine months, including a $5.8M trade name impairment, highlight ongoing portfolio optimization. The quarter underscores improving profitability and balance sheet strength despite a softer top line.
At the time of this filing, ONEW was trading at $12.25 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $203.6M. The 52-week trading range was $8.12 to $17.92. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.